RAFAEL HOLDINGS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
RAFAEL HOLDINGS, INC. (RFL) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $2.40 million as of 2020-07-31, per its 10-K filed 2020-10-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2020-10-29
- 2020-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $2.40M.
- 2019-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $1.20M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign |
|---|---|
| 2020-07-31 | $2.40M 10-K · filed 2020-10-29 |
| 2019-07-31 | $1.20M 10-Q · filed 2020-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |